Elevated insular glutamate in fibromyalgia is associated with experimental pain
Top Cited Papers
Open Access
- 29 September 2009
- journal article
- fibromyalgia
- Published by Wiley in Arthritis & Rheumatism
- Vol. 60 (10), 3146-3152
- https://doi.org/10.1002/art.24849
Abstract
Objective Central pain augmentation resulting from enhanced excitatory and/or decreased inhibitory neurotransmission is a proposed mechanism underlying the pathophysiology of functional pain syndromes such as fibromyalgia (FM). Multiple functional magnetic resonance imaging studies implicate the insula as a region of heightened neuronal activity in this condition. Since glutamate (Glu) is a major cortical excitatory neurotransmitter that functions in pain neurotransmission, we undertook this study to test our hypothesis that increased levels of insular Glu would be present in FM patients and that the concentration of this molecule would be correlated with pain report. Methods Nineteen FM patients and 14 age‐ and sex‐matched pain‐free controls underwent pressure pain testing and a proton magnetic resonance spectroscopy session in which the right anterior insula and right posterior insula were examined at rest. Results Compared with healthy controls, FM patients had significantly higher levels of Glu (mean ± SD 8.09 ± 0.72 arbitrary institutional units versus 6.86 ± 1.29 arbitrary institutional units; P = 0.009) and combined glutamine and Glu (i.e., Glx) (mean ± SD 12.38 ± 0.94 arbitrary institutional units versus 10.59 ± 1.48 arbitrary institutional units; P = 0.001) within the right posterior insula. No significant differences between groups were detected in any of the other major metabolites within this region (P > 0.05 for all comparisons), and no group differences were detected for any metabolite within the right anterior insula (P > 0.11 for all comparisons). Within the right posterior insula, higher levels of Glu and Glx were associated with lower pressure pain thresholds across both groups for medium pain (for Glu, r = −0.43, P = 0.012; for Glx, r = −0.50, P = 0.003). Conclusion Enhanced glutamatergic neurotransmission resulting from higher concentrations of Glu within the posterior insula may play a role in the pathophysiology of FM and other central pain augmentation syndromes.Keywords
This publication has 32 references indexed in Scilit:
- Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgiaArthritis & Rheumatism, 2008
- The Intravenous Ketamine Test Predicts Subsequent Response to an Oral Dextromethorphan Treatment Regimen in Fibromyalgia PatientsThe Journal of Pain, 2006
- Pregabalin Reduces the Release of Synaptic Vesicles from Cultured Hippocampal NeuronsMolecular Pharmacology, 2006
- A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgiaHuman Psychopharmacology: Clinical and Experimental, 2004
- Cerebrospinal Fluid Glutamate Levels in Chronic MigraineCephalalgia, 2004
- Empathy for Pain Involves the Affective but not Sensory Components of PainScience, 2004
- Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgiaArthritis & Rheumatism, 2002
- The prevalence and characteristics of fibromyalgia in the general populationArthritis & Rheumatism, 1995
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993
- The american college of rheumatology 1990 criteria for the classification of fibromyalgiaArthritis & Rheumatism, 1990